|
|
Article: Ambrilia Biopharma Provides Bi-Weekly Status Update.
- Article from:
- Marketwire Canada
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 Canadian Corporate News. News Provided by Comtex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MONTREAL, QUEBEC, Nov 3, 2009 (Marketwire via COMTEX) -- Ambrilia Biopharma Inc. (TSX:AMB) is providing today its bi-weekly Default Status Report under National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("Default Status Report").
On August 11, 2009, Ambrilia announced that the filing of its interim financial statements, management's discussion and analysis and related CEO and CFO certifications for the second quarter ended on June 30, 2009, was being delayed beyond the filing deadline of August 14, 2009.
Ambrilia also anticipates that the filing of its interim financial statements, management's discussion and analysis and ...